Five fast lessons from Reuters Pharma USA 2025
At Reuters Pharma USA 2025, industry leaders reinforced the need to put patients first, embrace agility, and simplify treatment access. The Swoop and...
1 min read
Emilie Branch
Jan 13, 2021 11:55:00 AM
Successfully engaging HCPs is key to ensuring a therapy reaches patients throughout the lifecycle, which is why insight into their priorities has never been more crucial. At conversationHEALTH, we have access to first-party data, including physician inquiries across specialties — these are the questions HCPs ask most frequently before they prescribe.
“What is the cost of this drug and does public insurance cover it?” Cost may affect a patient’s willingness to start a drug and remain compliant, which is why it’s consistently top of mind.
“How can I get samples sent to my clinic?” As most life sciences companies already know, providing samples to their prescribers at crucial intervals is paramount to a drug being adopted.
“Can you send me studies on this drug?” HCPs need clinical trial data to make informed decisions on the potential risks and benefits of a therapy, otherwise, they may not trust it.
“Where can this drug be obtained?” Quite simply, if patients can’t access a drug, they can’t take it.
“What support materials do you have for my patients?” HCPs frequently ask conversational agents for educational materials for their patients to supplement in-office counseling.
At Reuters Pharma USA 2025, industry leaders reinforced the need to put patients first, embrace agility, and simplify treatment access. The Swoop and...
Is it possible to truly move from sick care to health care? This year at Reuters Pharma USA, Co-founder and President of MyHealthTeam and Chief...
Traditional marketing strategies utilized by retail brands and airlines often don’t work for pharmaceutical manufacturers. Unlike other categories,...